Cargando…
Clinical impact of microbleeds in patients with Alzheimer’s disease
INTRODUCTION: Cerebral microbleeds (CMBs) are more frequent in patients with Alzheimer’s disease (AD) than in the general population. However, their clinical significance remains poorly understood. We carried out a multimodal approach to evaluate the impact of CMBs at a clinical, neuropsychological,...
Autores principales: | Vázquez-Justes, Daniel, Aguirregoicoa, Iván, Fernandez, Leandre, Carnes-Vendrell, Anna, Dakterzada, Faride, Sanjuan, Laura, Mena, Andreu, Piñol-Ripoll, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520821/ https://www.ncbi.nlm.nih.gov/pubmed/36175849 http://dx.doi.org/10.1186/s12877-022-03456-y |
Ejemplares similares
-
Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease
por: Dakterzada, Farida, et al.
Publicado: (2023) -
The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
por: Targa, Adriano D. S., et al.
Publicado: (2021) -
Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease
por: Dakterzada, Farida, et al.
Publicado: (2023) -
Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease
por: Dakterzada, Farida, et al.
Publicado: (2022) -
Proton pump inhibitors and the risk of Alzheimer’s disease and non-Alzheimer’s dementias
por: Torres-Bondia, Francisco, et al.
Publicado: (2020)